Raymond James Financial Inc. Makes New Investment in ProQR Therapeutics (NASDAQ:PRQR)
Raymond James Financial Inc. purchased a new position in ProQR Therapeutics (NASDAQ:PRQR – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 97,928 shares of the biopharmaceutical company’s stock, valued at approximately $260,000. A number of other institutional investors […]
Raymond James Financial Inc. purchased a new position in ProQR Therapeutics (NASDAQ:PRQR – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 97,928 shares of the biopharmaceutical company’s stock, valued at approximately $260,000. A number of other institutional investors […]
